Linked Life Data

11082907

Source:http://linkedlifedata.com/resource/pubmed/id/11082907

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2001-1-9
pubmed:abstractText
Oral administration of 20 mg per day Dydrogesterone was recommended in 28 pregnancies as a prevention of risks due to ultrasound guided amniocentesis. Reduction rate (3.6% vs. 5.0%) of uterine cramping and/or uterine contraction wave, observed in US were noticed comparing to the control (n = 40). No spontaneous abortion was noticed in both groups during two weeks follow up. Amniotic fluid leakage was noticed in 2.5% of control comparing to none in the Dydrogesterone group.
pubmed:language
pol
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0017-0011
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
709-13
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
[Dydrogesterone (Duphaston) in the prevention of risk of ultrasound guided amniocentesis].
pubmed:affiliation
II Kliniki Ginekologii Instytutu Ginekologii i Po?oznictwa Akademii Medycznej w Lodzi.
pubmed:publicationType
Journal Article, English Abstract